Cytokinetics Incorporated trailing returns
Cytokinetics Incorporated's 10-year return is +21.8% a year (CAGR) (+618.0% cumulative). How Cytokinetics Incorporated (CYTK) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through September 30, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-09-30. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | +0.4% | |
| 5 days | — | +0.2% | |
| 1 month | — | -8.6% | |
| YTD | — | +3.7% | |
| 1 year | +19.9% | +19.9% | |
| 5 years | +13.0% | +84.4% | |
| 10 years | +21.8% | +618.0% | |
| 20 years | +2.7% | +70.8% | |
| Since inception (2004) | -1.7% | -32.4% |
Growth of CYTK
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-09-30). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from CYTK's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Cytokinetics Incorporated's 10-year return?
- Over the last 10 years, Cytokinetics Incorporated (CYTK) returned about +21.8% a year annualized (+618.0% cumulative total return).
- What is Cytokinetics Incorporated's 20-year annualized return?
- Over the last 20 years, Cytokinetics Incorporated (CYTK) compounded at about +2.7% a year (+70.8% cumulative).
- What is Cytokinetics Incorporated's return since inception?
- Since 2004, Cytokinetics Incorporated (CYTK) has compounded at about -1.7% a year — -32.4% in total.